Patent ID: 8563034
Filing Date: 2013-10-22
Classification: A61K,A61P

Abstract:
1. A dual release oral tablet of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof, said tablet comprising: a) 20% by weight of the dexlansoprazole in powder form; b) 80% by weight of the dexlansoprazole in granule form, said granule form further comprising talc, colloidal silicon dioxide, magnesium stearate, hydrophobic agents, an alkali compound, fillers, binders, disintegrants or their mixtures; and c) a single enteric coating that dissolves at between pH 5.5 and 6.4, wherein particles of the dexlansoprazole in the powder form have d(0.9) equal to or less than 40 μm, and particles of the granule form have d(0.9) equal to or less than 500 μm.